explore -WSS

explore

author：knowledge 2025-09-06 04:13:14 - browse：46356

Kuldeep Singh Rajput -- health tech coverage from STAT — Kuldeep Singh Rajput has left his role as CEO of Biofourmis. World Economic Forum

A month after conducting significant layoffs, Biofourmis is out a CEO: Kuldeep Singh Rajput, one of the company’s founders, has quietly stepped down from his role.

A Biofourmis spokesperson confirmed Rajput’s departure to STAT on Wednesday, and said that while the company hunts for a new CEO it will be helmed by a committee of executives overseen by new board member Ben Wanamaker, a partner at Biofourmis investor General Atlantic. The Boston-based company was valued at $1.3 billion following a $320 million Series D financing round which closed last summer and brought big names to Biofourmis: CVS Health was an investor, and Omar Ishrak, former CEO of Medtronic, and Sachin Jain, CEO of the SCAN Health Plan joined the board.

Founded in 2015, Biofourmis has been developing a dizzying array of tech-enabled care offerings, including home-based care services for hospitals, clinical trials support for biopharma companies, and a pipeline of software-based interventions for heart failure and other conditions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Violet CEO on training clinicians to promote more inclusive care

WSS

Christmas in the PICU brings some surprising joy

Why health care costs have stayed mostly flat since 2010

Obesity drugs seen as possible treatment for liver disease MASH

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Why health care costs have stayed mostly flat since 2010

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

leisure time

explore

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

In utero gene editing: an explainer

Activists slam private health insurers over coverage restrictions

Community Health Systems hospitals under DOJ investigation

Virginia high school admissions case could be legal follow

With competition flaring, obesity drug hits goal in liver disease study

As demand for Covid shots wanes, Moderna seeks its next success

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Malaria cases in Florida and Texas: Here’s what you need to know

Obesity drugs seen as possible treatment for liver disease MASH

explore

PBM reform efforts get punted in Congress

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

Antivenom research: Lessons from HIV applied in search for universal antidote

Why palliative psychiatry is worth discussing

Medicare Advantage beneficiaries sue Humana over algorithm use

explore

Wikipedia

Wikipedia

focus